A primary challenge in the diagnosis of neurological disorders is differentiating between conditions that share…
Read MoreResearchers from La Jolla Institute for Immunology have discovered a genetic signature on the circulating…
Read MoreVaxxinity, a “purpose-driven biotechnology company committed to democratizing healthcare across the globe,” announced that it…
Read MoreThe Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded two grants to AC…
Read MoreBoston- and Atlanta-based clinical-stage pharmaceutical company Inhibikase Therapeutics, Inc. published the biochemical rationale for potentially…
Read MoreBoston-based biopharma company Yumanity Therapeutics announced last week that its drug candidate, YTX-7739, met its…
Read MoreA monoclonal antibody that binds to alpha-synuclein is advancing into a clinical trial after showing…
Read MoreA hallmark of Parkinson’s disease is the presence of Lewy bodies—abnormal clumps of protein primarily…
Read MoreResearchers at the University of Utah tested more than 150,000 compounds in search of candidates…
Read MoreIn a new paper published in Movement Disorders, researchers for the first time established a…
Read More
